Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Montelukast and Inhaled Nasal Steroid Tx in Adult Obstructive Sleep Apnea (OSA)

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
Merck Sharp & Dohme Corp.
Information provided by (Responsible Party):
Ann M. Romaker, MD, Romaker & Associates
ClinicalTrials.gov Identifier:
NCT01089647
First received: March 17, 2010
Last updated: May 29, 2013
Last verified: May 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: December 2013
  Estimated Primary Completion Date: June 2013 (Final data collection date for primary outcome measure)